Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient: letter
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2014
|
| In: |
Clinical cancer research
Year: 2014, Jahrgang: 20, Heft: 9, Pages: 2498-2499 |
| ISSN: | 1557-3265 |
| DOI: | 10.1158/1078-0432.CCR-13-2349 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1158/1078-0432.CCR-13-2349
|
| Verfasserangaben: | Mathias Bernhardt, Elias Orouji, Lionel Larribere, Christoffer Gebhardt, and Jochen Utikal |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1525305913 | ||
| 003 | DE-627 | ||
| 005 | 20220812152230.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 160209s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1158/1078-0432.CCR-13-2349 |2 doi | |
| 035 | |a (DE-627)1525305913 | ||
| 035 | |a (DE-576)455305919 | ||
| 035 | |a (DE-599)BSZ455305919 | ||
| 035 | |a (OCoLC)1340899767 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bernhardt, Mathias |e VerfasserIn |0 (DE-588)1026462541 |0 (DE-627)726762903 |0 (DE-576)371814448 |4 aut | |
| 245 | 1 | 0 | |a Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient |b letter |c Mathias Bernhardt, Elias Orouji, Lionel Larribere, Christoffer Gebhardt, and Jochen Utikal |
| 264 | 1 | |c 2014 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am: 09.02.2016 | ||
| 700 | 1 | |a Gebhardt, Christoffer |d 1976- |e VerfasserIn |0 (DE-588)13051151X |0 (DE-627)503031666 |0 (DE-576)298240289 |4 aut | |
| 700 | 1 | |a Utikal, Jochen |d 1974- |e VerfasserIn |0 (DE-588)1026463750 |0 (DE-627)726765015 |0 (DE-576)371816580 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical cancer research |d Philadelphia, Pa. [u.a.] : AACR, 1995 |g 20(2014), 9, Seite 2498-2499 |h Online-Ressource |w (DE-627)325489971 |w (DE-600)2036787-9 |w (DE-576)094502234 |x 1557-3265 |7 nnas |a Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient letter |
| 773 | 1 | 8 | |g volume:20 |g year:2014 |g number:9 |g pages:2498-2499 |g extent:2 |a Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient letter |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1158/1078-0432.CCR-13-2349 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20160209 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 1026463750 |a Utikal, Jochen |m 1026463750:Utikal, Jochen |d 60000 |e 60000PU1026463750 |k 0/60000/ |p 5 |y j | ||
| 998 | |g 13051151X |a Gebhardt, Christoffer |m 13051151X:Gebhardt, Christoffer |d 60000 |d 61900 |e 60000PG13051151X |e 61900PG13051151X |k 0/60000/ |k 1/60000/61900/ |p 4 | ||
| 998 | |g 1026462541 |a Bernhardt, Mathias |m 1026462541:Bernhardt, Mathias |d 60000 |d 61900 |e 60000PB1026462541 |e 61900PB1026462541 |k 0/60000/ |k 1/60000/61900/ |p 1 |x j | ||
| 999 | |a KXP-PPN1525305913 |e 2897711582 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am: 09.02.2016"],"language":["eng"],"recId":"1525305913","title":[{"title":"Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient","subtitle":"letter","title_sort":"Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient"}],"person":[{"roleDisplay":"VerfasserIn","display":"Bernhardt, Mathias","role":"aut","family":"Bernhardt","given":"Mathias"},{"display":"Gebhardt, Christoffer","roleDisplay":"VerfasserIn","role":"aut","family":"Gebhardt","given":"Christoffer"},{"roleDisplay":"VerfasserIn","display":"Utikal, Jochen","role":"aut","family":"Utikal","given":"Jochen"}],"physDesc":[{"extent":"2 S."}],"relHost":[{"title":[{"title_sort":"Clinical cancer research","title":"Clinical cancer research"}],"recId":"325489971","corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"American Association for Cancer Research"}],"language":["eng"],"disp":"Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient letterClinical cancer research","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 08.06.2023","Fortsetzung der Druck-Ausgabe"],"part":{"year":"2014","pages":"2498-2499","issue":"9","text":"20(2014), 9, Seite 2498-2499","volume":"20","extent":"2"},"pubHistory":["1.1995 -"],"name":{"displayForm":["American Association for Cancer Research"]},"id":{"issn":["1557-3265"],"zdb":["2036787-9"],"eki":["325489971"]},"origin":[{"dateIssuedDisp":"1995-","dateIssuedKey":"1995","publisher":"AACR","publisherPlace":"Philadelphia, Pa. [u.a.]"}],"physDesc":[{"extent":"Online-Ressource"}]}],"origin":[{"dateIssuedDisp":"2014","dateIssuedKey":"2014"}],"id":{"doi":["10.1158/1078-0432.CCR-13-2349"],"eki":["1525305913"]},"name":{"displayForm":["Mathias Bernhardt, Elias Orouji, Lionel Larribere, Christoffer Gebhardt, and Jochen Utikal"]}} | ||
| SRT | |a BERNHARDTMEFFICACYOF2014 | ||